Sona Nanotech Inc. (SONA.CN) Research
Based in Halifax, Canada, Sona Nanotech Inc. is a life sciences company focused on nanotechnology. It develops and commercializes gold nanorod solutions primarily for diagnostic applications. Their product portfolio includes the Nanotech COVID-19 Lateral Flow Assay, an immunochromatographic test designed to detect the SARS-CoV-2 spike protein antigen in saliva from individuals suspected of having the virus. The company also offers Gemini and Omni gold nanorods, with the latter specifically engineered for medical uses, in addition to providing contract services. These versatile products are utilized in a wide array of applications, such as targeted drug delivery, environmental and food safety monitoring, cellular visualization, cancer therapy, liposuction treatments, and diagnostic tools for medical, consumer, military, and veterinary sectors.
Market snapshot
- Symbol
- SONA.CN
- Price
- $0.29
- Day change
- -10.94%
- Market cap
- $32.6M
- P/E ratio
- -10.87x
- 52-week range
- 0.26-0.91
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- Next earnings
- in 4 days
Recent news
- Dow rockets higher as Strait of Hormuz stays open, talks eyed
4:20pm: Easing tensions Markets finished the session on a strong note, with major US indexes extending their winning streak as geopolitical tensions showed...
- Iran's blockade of the Strait of Hormuz has wiped out a third of global helium supply, and the scramble for secure alternatives has begun
The gas keeping the world's MRI scanners running and AI chips cool is suddenly in critically short supply. Six ASX-listed companies could find themselves in...
- Dow powers higher as oil slump, easing tensions lift stocks
12:55pm: Sliding oil propels stocks "Crude futures prices fell sharply - dropping over 10% to below $86 per barrel and reaching near five-week lows - after...
Peer companies
Open Sona Nanotech Inc. (SONA.CN) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.